Galiximab

(Synonyms: IDEC 114; Anti-Human CD80 Recombinant Antibody)
1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

Galiximab (IDEC-114) is a primatized monoclonal IgG1 antibody targeting CD80. Galiximab variable regions are primatized, and the constant regions are humanized. Galiximab induces antibody-dependent cellular cytotoxicity by blocking CD80-CD28 binding. Galiximab has antitumor activity and can induce apoptosis in tumor cells. Galiximab can be used in the research of relapsed Hodgkin lymphoma and solid tumors.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.23%
  • No. CAS: 357613-77-5
  • Peso molecular:145.24 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Galiximab

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00